Advertisement

Topics

ANI Re-Commercializes Another Discontinued ANDA Product

06:00 EDT 21 Jun 2017 | PharmPro

ANI Pharmaceuticals announces launch of Diphenoxylate HCl and Atropine Sulfate tablets. It marks the seventh product that ANI has successfully re-commercialized from its portfolio of acquired discontinued ANDA products.
Contributed Author: 
ANI Pharmaceuticals, Inc.

Original Article: ANI Re-Commercializes Another Discontinued ANDA Product

NEXT ARTICLE

More From BioPortfolio on "ANI Re-Commercializes Another Discontinued ANDA Product"

Advertisement
Quick Search
Advertisement
Advertisement